3.8.0.1 html 275 345 1 false 69 0 false 11 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.biohavenpharma.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.biohavenpharma.com/role/StatementConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.biohavenpharma.com/role/StatementConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://www.biohavenpharma.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 00300 - Statement - CONSOLIDATED STATEMENT OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT) Sheet http://www.biohavenpharma.com/role/StatementConsolidatedStatementOfConvertiblePreferredSharesAndShareholdersEquityDeficit CONSOLIDATED STATEMENT OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT) Statements 5 false false R6.htm 00305 - Statement - CONSOLIDATED STATEMENT OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT) (PARENTHETICAL) Sheet http://www.biohavenpharma.com/role/StatementConsolidatedStatementOfConvertiblePreferredSharesAndShareholdersEquityDeficitParenthetical CONSOLIDATED STATEMENT OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT) (PARENTHETICAL) Statements 6 false false R7.htm 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.biohavenpharma.com/role/StatementConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 10101 - Disclosure - Nature of the Business and Basis of Presentation Sheet http://www.biohavenpharma.com/role/DisclosureNatureOfBusinessAndBasisOfPresentation Nature of the Business and Basis of Presentation Notes 8 false false R9.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.biohavenpharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 10301 - Disclosure - Fair Value of Financial Assets and Liabilities Sheet http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilities Fair Value of Financial Assets and Liabilities Notes 10 false false R11.htm 10401 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.biohavenpharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 11 false false R12.htm 10501 - Disclosure - Equity Method Investment Sheet http://www.biohavenpharma.com/role/DisclosureEquityMethodInvestment Equity Method Investment Notes 12 false false R13.htm 10601 - Disclosure - Accrued Expenses Sheet http://www.biohavenpharma.com/role/DisclosureAccruedExpenses Accrued Expenses Notes 13 false false R14.htm 10701 - Disclosure - Notes Payable Notes http://www.biohavenpharma.com/role/DisclosureNotesPayable Notes Payable Notes 14 false false R15.htm 10801 - Disclosure - Warrants Sheet http://www.biohavenpharma.com/role/DisclosureWarrants Warrants Notes 15 false false R16.htm 10901 - Disclosure - Convertible Preferred Shares Sheet http://www.biohavenpharma.com/role/DisclosureConvertiblePreferredShares Convertible Preferred Shares Notes 16 false false R17.htm 11001 - Disclosure - Common Shares Sheet http://www.biohavenpharma.com/role/DisclosureCommonShares Common Shares Notes 17 false false R18.htm 11101 - Disclosure - Share-Based Compensation Sheet http://www.biohavenpharma.com/role/DisclosureShareBasedCompensation Share-Based Compensation Notes 18 false false R19.htm 11201 - Disclosure - License Agreements Sheet http://www.biohavenpharma.com/role/DisclosureLicenseAgreements License Agreements Notes 19 false false R20.htm 11301 - Disclosure - Net Loss per Share Sheet http://www.biohavenpharma.com/role/DisclosureNetLossPerShare Net Loss per Share Notes 20 false false R21.htm 11401 - Disclosure - Commitments and Contingencies Sheet http://www.biohavenpharma.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 11501 - Disclosure - Related Party Transactions Sheet http://www.biohavenpharma.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 22 false false R23.htm 11601 - Disclosure - Acquisition of Biohaven Pharmaceuticals, Inc. Sheet http://www.biohavenpharma.com/role/DisclosureAcquisitionOfBiohavenPharmaceuticalsInc Acquisition of Biohaven Pharmaceuticals, Inc. Notes 23 false false R24.htm 11701 - Disclosure - Subsequent Events Sheet http://www.biohavenpharma.com/role/DisclosureSubsequentEvents Subsequent Events Notes 24 false false R25.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.biohavenpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.biohavenpharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies 25 false false R26.htm 30303 - Disclosure - Fair Value of Financial Assets and Liabilities (Tables) Sheet http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilitiesTables Fair Value of Financial Assets and Liabilities (Tables) Tables http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilities 26 false false R27.htm 30403 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.biohavenpharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.biohavenpharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets 27 false false R28.htm 30503 - Disclosure - Equity Method Investment (Tables) Sheet http://www.biohavenpharma.com/role/DisclosureEquityMethodInvestmentTables Equity Method Investment (Tables) Tables http://www.biohavenpharma.com/role/DisclosureEquityMethodInvestment 28 false false R29.htm 30603 - Disclosure - Accrued Expenses (Tables) Sheet http://www.biohavenpharma.com/role/DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.biohavenpharma.com/role/DisclosureAccruedExpenses 29 false false R30.htm 31103 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.biohavenpharma.com/role/DisclosureShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://www.biohavenpharma.com/role/DisclosureShareBasedCompensation 30 false false R31.htm 31303 - Disclosure - Net Loss per Share (Tables) Sheet http://www.biohavenpharma.com/role/DisclosureNetLossPerShareTables Net Loss per Share (Tables) Tables http://www.biohavenpharma.com/role/DisclosureNetLossPerShare 31 false false R32.htm 31403 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.biohavenpharma.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.biohavenpharma.com/role/DisclosureCommitmentsAndContingencies 32 false false R33.htm 40101 - Disclosure - Nature of the Business and Basis of Presentation (Details) Sheet http://www.biohavenpharma.com/role/DisclosureNatureOfBusinessAndBasisOfPresentationDetails Nature of the Business and Basis of Presentation (Details) Details http://www.biohavenpharma.com/role/DisclosureNatureOfBusinessAndBasisOfPresentation 33 false false R34.htm 40102 - Disclosure - Nature of the Business and Basis of Presentation - Stock Split & Public Offering (Details) Sheet http://www.biohavenpharma.com/role/DisclosureNatureOfBusinessAndBasisOfPresentationStockSplitPublicOfferingDetails Nature of the Business and Basis of Presentation - Stock Split & Public Offering (Details) Details 34 false false R35.htm 40103 - Disclosure - Nature of the Business and Basis of Presentation - Going Concern(Details) Sheet http://www.biohavenpharma.com/role/DisclosureNatureOfBusinessAndBasisOfPresentationGoingConcernDetails Nature of the Business and Basis of Presentation - Going Concern(Details) Details 35 false false R36.htm 40201 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.biohavenpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.biohavenpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies 36 false false R37.htm 40301 - Disclosure - Fair Value of Financial Assets and Liabilities (Details) Sheet http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilitiesDetails Fair Value of Financial Assets and Liabilities (Details) Details http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilitiesTables 37 false false R38.htm 40302 - Disclosure - Fair Value of Financial Assets and Liabilities - Valuation of Contingent Equity Liability (Details) Sheet http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilitiesValuationOfContingentEquityLiabilityDetails Fair Value of Financial Assets and Liabilities - Valuation of Contingent Equity Liability (Details) Details 38 false false R39.htm 40303 - Disclosure - Fair Value of Financial Assets and Liabilities - Fair values of the company's liabilities (Details) Sheet http://www.biohavenpharma.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilitiesFairValuesOfCompanySLiabilitiesDetails Fair Value of Financial Assets and Liabilities - Fair values of the company's liabilities (Details) Details 39 false false R40.htm 40401 - Disclosure - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.biohavenpharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets (Details) Details http://www.biohavenpharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables 40 false false R41.htm 40501 - Disclosure - Equity Method Investment - Stock purchase agreement with Kleo (Details) Sheet http://www.biohavenpharma.com/role/DisclosureEquityMethodInvestmentStockPurchaseAgreementWithKleoDetails Equity Method Investment - Stock purchase agreement with Kleo (Details) Details 41 false false R42.htm 40502 - Disclosure - Equity Method Investment - Carrying value and Summarized financial information for Kleo (Details) Sheet http://www.biohavenpharma.com/role/DisclosureEquityMethodInvestmentCarryingValueAndSummarizedFinancialInformationForKleoDetails Equity Method Investment - Carrying value and Summarized financial information for Kleo (Details) Details 42 false false R43.htm 40601 - Disclosure - Accrued Expenses (Details) Sheet http://www.biohavenpharma.com/role/DisclosureAccruedExpensesDetails Accrued Expenses (Details) Details http://www.biohavenpharma.com/role/DisclosureAccruedExpensesTables 43 false false R44.htm 40701 - Disclosure - Notes Payable - Credit Agreement (Details) Notes http://www.biohavenpharma.com/role/DisclosureNotesPayableCreditAgreementDetails Notes Payable - Credit Agreement (Details) Details 44 false false R45.htm 40702 - Disclosure - Notes Payable - Notes Payable to Related Parties (Details) Notes http://www.biohavenpharma.com/role/DisclosureNotesPayableNotesPayableToRelatedPartiesDetails Notes Payable - Notes Payable to Related Parties (Details) Details 45 false false R46.htm 40801 - Disclosure - Warrants - ALS Biopharma Warrants (Details) Sheet http://www.biohavenpharma.com/role/DisclosureWarrantsAlsBiopharmaWarrantsDetails Warrants - ALS Biopharma Warrants (Details) Details 46 false false R47.htm 40802 - Disclosure - Warrants - Guarantor and Co-Guarantor Warrants (Details) Sheet http://www.biohavenpharma.com/role/DisclosureWarrantsGuarantorAndCoGuarantorWarrantsDetails Warrants - Guarantor and Co-Guarantor Warrants (Details) Details 47 false false R48.htm 40803 - Disclosure - Warrants - Trout Warrants (Details) Sheet http://www.biohavenpharma.com/role/DisclosureWarrantsTroutWarrantsDetails Warrants - Trout Warrants (Details) Details 48 false false R49.htm 40901 - Disclosure - Convertible Preferred Shares (Details) Sheet http://www.biohavenpharma.com/role/DisclosureConvertiblePreferredSharesDetails Convertible Preferred Shares (Details) Details http://www.biohavenpharma.com/role/DisclosureConvertiblePreferredShares 49 false false R50.htm 41001 - Disclosure - Common Shares (Details) Sheet http://www.biohavenpharma.com/role/DisclosureCommonSharesDetails Common Shares (Details) Details http://www.biohavenpharma.com/role/DisclosureCommonShares 50 false false R51.htm 41002 - Disclosure - Common Shares- Other Info (Details) Sheet http://www.biohavenpharma.com/role/DisclosureCommonSharesOtherInfoDetails Common Shares- Other Info (Details) Details 51 false false R52.htm 41101 - Disclosure - Share-Based Compensation - 2014 Equity Incentive Plan (Details) Sheet http://www.biohavenpharma.com/role/DisclosureShareBasedCompensation2014EquityIncentivePlanDetails Share-Based Compensation - 2014 Equity Incentive Plan (Details) Details 52 false false R53.htm 41102 - Disclosure - Share-Based Compensation - 2017 Equity Incentive Plan and Employee Share Purchase Plan (Details) Sheet http://www.biohavenpharma.com/role/DisclosureShareBasedCompensation2017EquityIncentivePlanAndEmployeeSharePurchasePlanDetails Share-Based Compensation - 2017 Equity Incentive Plan and Employee Share Purchase Plan (Details) Details 53 false false R54.htm 41103 - Disclosure - Share-Based Compensation - Stock Option Valuation (Details) Sheet http://www.biohavenpharma.com/role/DisclosureShareBasedCompensationStockOptionValuationDetails Share-Based Compensation - Stock Option Valuation (Details) Details 54 false false R55.htm 41104 - Disclosure - Share-Based Compensation - Stock Options (Details) Sheet http://www.biohavenpharma.com/role/DisclosureShareBasedCompensationStockOptionsDetails Share-Based Compensation - Stock Options (Details) Details 55 false false R56.htm 41105 - Disclosure - Share-Based Compensation (Details) Sheet http://www.biohavenpharma.com/role/DisclosureShareBasedCompensationDetails Share-Based Compensation (Details) Details http://www.biohavenpharma.com/role/DisclosureShareBasedCompensationTables 56 false false R57.htm 41201 - Disclosure - License Agreements - Yale Agreement (Details) Sheet http://www.biohavenpharma.com/role/DisclosureLicenseAgreementsYaleAgreementDetails License Agreements - Yale Agreement (Details) Details 57 false false R58.htm 41202 - Disclosure - License Agreements - MGH Agreement (Details) Sheet http://www.biohavenpharma.com/role/DisclosureLicenseAgreementsMghAgreementDetails License Agreements - MGH Agreement (Details) Details 58 false false R59.htm 41203 - Disclosure - License Agreements - ALS Biopharma Agreement (Details) Sheet http://www.biohavenpharma.com/role/DisclosureLicenseAgreementsAlsBiopharmaAgreementDetails License Agreements - ALS Biopharma Agreement (Details) Details 59 false false R60.htm 41204 - Disclosure - License Agreements - Rutger Agreement (Details) Sheet http://www.biohavenpharma.com/role/DisclosureLicenseAgreementsRutgerAgreementDetails License Agreements - Rutger Agreement (Details) Details 60 false false R61.htm 41205 - Disclosure - License Agreements - BMS Agreement (Details) Sheet http://www.biohavenpharma.com/role/DisclosureLicenseAgreementsBmsAgreementDetails License Agreements - BMS Agreement (Details) Details 61 false false R62.htm 41206 - Disclosure - License Agreements - AstraZeneca Agreement (Details) Sheet http://www.biohavenpharma.com/role/DisclosureLicenseAgreementsAstrazenecaAgreementDetails License Agreements - AstraZeneca Agreement (Details) Details 62 false false R63.htm 41207 - Disclosure - License Agreements - Catalent Agreement (Details) Sheet http://www.biohavenpharma.com/role/DisclosureLicenseAgreementsCatalentAgreementDetails License Agreements - Catalent Agreement (Details) Details 63 false false R64.htm 41301 - Disclosure - Net Loss per Share (Details) Sheet http://www.biohavenpharma.com/role/DisclosureNetLossPerShareDetails Net Loss per Share (Details) Details http://www.biohavenpharma.com/role/DisclosureNetLossPerShareTables 64 false false R65.htm 41302 - Disclosure - Net Loss per Share - Antidilutive Securities Excluded from EPS (Details) Sheet http://www.biohavenpharma.com/role/DisclosureNetLossPerShareAntidilutiveSecuritiesExcludedFromEpsDetails Net Loss per Share - Antidilutive Securities Excluded from EPS (Details) Details 65 false false R66.htm 41303 - Disclosure - Net Loss per Share - Warrants and Contingent Equity Liability (Details) Sheet http://www.biohavenpharma.com/role/DisclosureNetLossPerShareWarrantsAndContingentEquityLiabilityDetails Net Loss per Share - Warrants and Contingent Equity Liability (Details) Details 66 false false R67.htm 41401 - Disclosure - Commitments and Contingencies - Lease Agreement (Details) Sheet http://www.biohavenpharma.com/role/DisclosureCommitmentsAndContingenciesLeaseAgreementDetails Commitments and Contingencies - Lease Agreement (Details) Details 67 false false R68.htm 41402 - Disclosure - Commitments and Contingencies - Research Commitments (Details) Sheet http://www.biohavenpharma.com/role/DisclosureCommitmentsAndContingenciesResearchCommitmentsDetails Commitments and Contingencies - Research Commitments (Details) Details 68 false false R69.htm 41501 - Disclosure - Related Party Transactions (Details) Sheet http://www.biohavenpharma.com/role/DisclosureRelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.biohavenpharma.com/role/DisclosureRelatedPartyTransactions 69 false false R70.htm 41601 - Disclosure - Acquisition of Biohaven Pharmaceuticals, Inc (Details) Sheet http://www.biohavenpharma.com/role/DisclosureAcquisitionOfBiohavenPharmaceuticalsIncDetails Acquisition of Biohaven Pharmaceuticals, Inc (Details) Details http://www.biohavenpharma.com/role/DisclosureAcquisitionOfBiohavenPharmaceuticalsInc 70 false false R71.htm 41701 - Disclosure - Subsequent Events (Details) Sheet http://www.biohavenpharma.com/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) Details http://www.biohavenpharma.com/role/DisclosureSubsequentEvents 71 false false All Reports Book All Reports bhvn-20170930.xml bhvn-20170930.xsd bhvn-20170930_cal.xml bhvn-20170930_def.xml bhvn-20170930_lab.xml bhvn-20170930_pre.xml http://xbrl.sec.gov/dei/2014-01-31 http://fasb.org/us-gaap/2016-01-31 true true